Key result
Noninvasive imaging modalities can quantify atherosclerotic plaque inflammation, potentially aiding in drug testing, risk stratification, and understanding disease biology.
Noninvasive imaging of plaque inflammation may aid in testing novel antiatherosclerosis drugs and identifying patients at risk of plaque rupture.
No takes yet. Share an insight, caveat, or question.
May support drug testing and risk stratification; leaves open prospective outcome validation before clinical use.
Rudd et al. (2009) conducted a review in Atherosclerosis. Inflammation imaging modalities was evaluated. Noninvasive imaging modalities can quantify atherosclerotic plaque inflammation, potentially aiding in drug testing, risk stratification, and understanding disease biology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: